Sun Pharma, Ranbaxy to sell 7 products to meet CCI conditions
While approving their USD 4-billion merger, Competition Commission of India (CCI) has asked the two companies to divest seven products to address anti-competitive concerns.
Dec 08, 2014, 20:26 PM IST